607 related articles for article (PubMed ID: 33453371)
1. Immortal time bias exaggerates the effect of metformin on the risk of gastric cancer: A meta-analysis.
Wang YB; Tan LM; Luo L; Yan S; Huang Q; Wang Y; Deng T; Shi Y; Deng Y; Jin YH
Pharmacol Res; 2021 Mar; 165():105425. PubMed ID: 33453371
[TBL] [Abstract][Full Text] [Related]
2. Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Wei M; Liu Y; Bi Y; Zhang ZJ
Int J Cancer; 2019 Oct; 145(7):1822-1828. PubMed ID: 30848544
[TBL] [Abstract][Full Text] [Related]
3. Metformin and Reduced Risk of Cancer in the Hong Kong Diabetes Registry: Real Effect or Immortal Time Bias?
Zhang ZJ
J Gen Intern Med; 2019 Jul; 34(7):1154-1157. PubMed ID: 31025306
[TBL] [Abstract][Full Text] [Related]
4. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
5. Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study.
Lacroix O; Couttenier A; Vaes E; Cardwell CR; De Schutter H; Robert A
Cancer Epidemiol; 2018 Apr; 53():149-155. PubMed ID: 29453032
[TBL] [Abstract][Full Text] [Related]
6. No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies.
Wang Y; Liu X; Yan P; Bi Y; Liu Y; Zhang ZJ
Curr Pharm Des; 2019; 25(23):2595-2601. PubMed ID: 31333095
[TBL] [Abstract][Full Text] [Related]
7. Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis.
Zhang M; He JQ
Eur J Clin Pharmacol; 2020 Feb; 76(2):149-159. PubMed ID: 31786617
[TBL] [Abstract][Full Text] [Related]
8. Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta-analysis of population-based cohort studies.
Zhang Y; Zhang Y; Shi X; Han J; Lin B; Peng W; Mei Z; Lin Y
Diabet Med; 2022 Jun; 39(6):e14821. PubMed ID: 35213749
[TBL] [Abstract][Full Text] [Related]
9. Association between history of cholecystectomy and risk of gastric cancer: a meta-analysis of epidemiological studies.
Sun M; Ma T; Yuan H
BMJ Open; 2023 Aug; 13(8):e057138. PubMed ID: 37640459
[TBL] [Abstract][Full Text] [Related]
10. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
Shuai Y; Li C; Zhou X
Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
[TBL] [Abstract][Full Text] [Related]
12. Coffee consumption and the risk of incident gastric cancer--A meta-analysis of prospective cohort studies.
Deng W; Yang H; Wang J; Cai J; Bai Z; Song J; Zhang Z
Nutr Cancer; 2016; 68(1):40-7. PubMed ID: 26710312
[TBL] [Abstract][Full Text] [Related]
13. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies.
Li L; Gan Y; Wu C; Qu X; Sun G; Lu Z
BMC Cancer; 2015 Oct; 15():733. PubMed ID: 26481317
[TBL] [Abstract][Full Text] [Related]
14. Association of metformin use with cancer incidence and mortality: a meta-analysis.
Zhang P; Li H; Tan X; Chen L; Wang S
Cancer Epidemiol; 2013 Jun; 37(3):207-18. PubMed ID: 23352629
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis.
Yoon JM; Son KY; Eom CS; Durrance D; Park SM
World J Gastroenterol; 2013 Feb; 19(6):936-45. PubMed ID: 23429469
[TBL] [Abstract][Full Text] [Related]
16. Statins are associated with reduced risk of gastric cancer: a meta-analysis.
Wu XD; Zeng K; Xue FQ; Chen JH; Chen YQ
Eur J Clin Pharmacol; 2013 Oct; 69(10):1855-60. PubMed ID: 23748751
[TBL] [Abstract][Full Text] [Related]
17. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.
Kim YI; Kim SY; Cho SJ; Park JH; Choi IJ; Lee YJ; Lee EK; Kook MC; Kim CG; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2014 Apr; 39(8):854-63. PubMed ID: 24612291
[TBL] [Abstract][Full Text] [Related]
18. Metformin use and prostate cancer risk: A meta-analysis of cohort studies.
Feng Z; Zhou X; Liu N; Wang J; Chen X; Xu X
Medicine (Baltimore); 2019 Mar; 98(12):e14955. PubMed ID: 30896668
[TBL] [Abstract][Full Text] [Related]
19. Association of metformin use and cancer incidence: a systematic review and meta-analysis.
O'Connor L; Bailey-Whyte M; Bhattacharya M; Butera G; Hardell KNL; Seidenberg AB; Castle PE; Loomans-Kropp HA
J Natl Cancer Inst; 2024 Apr; 116(4):518-529. PubMed ID: 38291943
[TBL] [Abstract][Full Text] [Related]
20. Intake of Anthocyanins and Gastric Cancer Risk: A Comprehensive Meta-Analysis on Cohort and Case-Control Studies.
Yang D; Wang X; Yuan W; Chen Z
J Nutr Sci Vitaminol (Tokyo); 2019; 65(1):72-81. PubMed ID: 30814415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
